Literature DB >> 20694775

Effect of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension.

Hao Li1, Long-tao Liu, Wen-ming Zhao, Jian-gang Liu, Ming-jiang Yao, Yong-xiang Han, Yan-peng Shen, Xing-dong Liu, Li Liu, Xue-mei Wang, Lin-lin Cai, Jie Guan.   

Abstract

OBJECTIVE: To observe the effect of Chinese medical regimen and integrative medical regimen on quality of life and early renal impairment in elderly patients with isolated systolic hypertension (EISH).
METHODS: A multi-center, randomized, double-blinded controlled trail was adopted. A total of 270 cases of EISH were randomly divided into 3 groups: Chinese medicine group (CM), combination group and Western medicine group (WM). The course of treatment was 4 weeks. The clinical blood pressure, integral of quality of life (SF-36 scale), immunoglubin G (IgG), microalbumin (mALB), beta(2)-microglobulin (beta(2)-MG), transferrin (TRF) and N-acetyl-beta'-D-glucosa-minidase (NAG) in urine were determined before and after the treatment.
RESULTS: After treatment, systolic blood pressure depressed significantly in each group (P<0.05), and the combination group was superior to CM or WM group in depressing SBP (P<0.05); in each group, integral of quality of life improved in different degree, and combination group was superior to WM group in all 8 dimensions (P<0.05). The level of mALB and beta(2)-MG in urine decreased in all groups (P<0.05), and the combination group was superior to CM group or WM group in decreasing mALB (P<0.05).
CONCLUSIONS: Chinese medical regimen has affirmative effect in treating EISH patients, and could lower the systolic blood pressure, improve quality of life and early renal impairment of the patients, and integrative medical regimen has superiority on account of cooperation, and deserves further study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694775     DOI: 10.1007/s11655-010-0216-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  5 in total

Review 1.  Clinical practice. Isolated systolic hypertension in the elderly.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 3.  Progression of renal failure -- the role of hypertension.

Authors:  J A Whitworth
Journal:  Ann Acad Med Singapore       Date:  2005-01       Impact factor: 2.473

4.  Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.

Authors:  Frank Stam; Coen van Guldener; Casper G Schalkwijk; Piet M ter Wee; Ab J M Donker; Coen D A Stehouwer
Journal:  Nephrol Dial Transplant       Date:  2003-05       Impact factor: 5.992

5.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

  5 in total
  10 in total

1.  Therapeutic evaluation on complex interventions of integrative medicine and the potential role of data mining.

Authors:  Yu Qiu; Hao Xu; Dong-yan Zhao
Journal:  Chin J Integr Med       Date:  2010-09-25       Impact factor: 1.978

2.  Xinfeng capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function--a randomized controlled clinical trial.

Authors:  Lei Wan; Jian Liu; Chuan-bing Huang; Yuan Wang; Xi Chen; Wan-dong Zhang; Gui-zhen Wang; Hai-xia Fan; Yao Ge; Rui-lian Chen; Yun-xiang Cao; Rui-kai Zong; Tian-yang Liu
Journal:  Chin J Integr Med       Date:  2016-01-27       Impact factor: 1.978

3.  Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Bo Feng; Jizheng Ma; Xinliang Du; Pengqian Wang; Fuyong Chu; Jun Li; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-20       Impact factor: 2.629

4.  Control strategy on hypertension in chinese medicine.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2011-12-12       Impact factor: 2.629

5.  Assessing descriptions of scalability for hypertension control interventions implemented in low-and middle-income countries: A systematic review.

Authors:  Joyce Gyamfi; Dorice Vieira; Juliet Iwelunmor; Beverly Xaviera Watkins; Olajide Williams; Emmanuel Peprah; Gbenga Ogedegbe; John P Allegrante
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

6.  Evidence-based chinese medicine for hypertension.

Authors:  Jie Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

7.  Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Kuiwu Yao; Xiaochen Yang; Wei Liu; Bo Feng; Jizheng Ma; Xinliang Du; Pengqian Wang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-11       Impact factor: 2.629

8.  Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials.

Authors:  Jie Wang; Bo Feng; Xiaochen Yang; Wei Liu; Yongmei Liu; Yun Zhang; Gui Yu; Shengjie Li; Yuqing Zhang; Xingjiang Xiong
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-24       Impact factor: 2.629

Review 9.  Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science.

Authors:  Xingjiang Xiong; Xiaochen Yang; Yongmei Liu; Yun Zhang; Pengqian Wang; Jie Wang
Journal:  Hypertens Res       Date:  2013-04-04       Impact factor: 3.872

10.  Trends in the treatment of hypertension from the perspective of traditional chinese medicine.

Authors:  Xingjiang Xiong; Xiaochen Yang; Wei Liu; Fuyong Chu; Pengqian Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.